Fibrocell
-
Exton’s Fibrocell Granted Rare Designation by FDA
Exton’s Fibrocell has been granted the Rare Pediatric Disease Designation by the Food and Drug Administration for its gene therapy candidate to treat children with…
-
Fibrocell’s ‘Butterfly Child’ Treatment Clears First Patient
Fibrocell Science’s newest gene therapy treatment is now spreading its wings after helping treat the first patient suffering from fragile, easily blistered skin associated with…
-
Exton’s Fibrocell Completes Transition with Changes in Leadership
Exton’s Fibrocell Science has made some changes in its leadership by appointing John Maslowski as Chief Executive Officer and Douglas Swirsky as Chairman of the…
-
Exton’s Fibrocell Science Cuts Workforce in Half
Exton’s Fibrocell Science has let go of 24 employees and is actively looking for a buyer for azficel-T, its experimental treatment for vocal cord scarring,…
-
Fibrocell Shares Plummet Following Disappointing Clinical Study
Exton based Fibrocell Science saw over a third of its share value disappear on Wednesday, after it announced disappointing results from the second-stage clinical trial on…
-
Chester County Daily News Business Briefs
VISTA Today Daily News Business Briefs are concise stories that bring you up to date with what’s going on around Chester County. This morning: Fox…
-
Chester County Business Daily News Briefs
VISTA Today’s daily news briefs are concise, accurate stories that focus on Chester County companies. New Brandywine Hospital CEO Appointed The Brandywine Hospital Board of…
-
Chester County Business Daily News Briefs
Chester County business daily news briefs review yesterday’s business stories important to Chester County and beyond. Chester County Library System’s (CCLS) Annual Report released last…
-
Flash Chesco Stock Alert
Don’t look now but shares of Fibrocell (FCSC: NYSE), the Exton-based company focused on developing treatments for rare and serious skin and connective tissue damage…
-
Fibrocell Is Late In Filing 1Q Report
Chester County cell therapy developer Fibrocell Science Inc. of Exton expects to file its first quarter financial report this week after a five-day delay to…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
